Apoptosis and cell proliferation in the development of gastric carcinomas: Associations with c-myc and p53 protein expression

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 9, 2002, Pages 966-972

  Ishii, Hideaki H ^a   Gobé, Glenda C ^b   Pan, Wenshen ^a   Yoneyama, Juichi ^a   Ebihara, Yoshiro ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Adenocarcinoma; Ki 67; Oncogenes; Tumor suppressor genes

Indexed keywords

KI 67 ANTIGEN; MYC PROTEIN; PROTEIN P53;

ADVANCED CANCER; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STOMACH CARCINOMA; TUMOR GROWTH;

EID: 0036379716     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02805.x     Document Type: Article

References (42)

1. Kerr J, Winterford C, Harmon B. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994; 73: 2013-16.
2. King K, Cidlowski J. Cell cycle regulation and apoptosis. Annu. Rev. Physiol. 1998; 60: 601-17.
3. Kyprianou N, Bruckheimer E, Guo Y. Cell proliferation and apoptosis in prostate cancer. Significance in disease progression and therapy. Histol. Histopathol. 2000; 15: 1211-23.
4. Arends MJ, McGregor AH, Wyllie AH. Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes. Am. J. Pathol. 1994; 144: 1045-57.
5. Staunton MJ, Gaffney EF. Apoptosis: Basic concepts and potential significance in human cancer. Arch. Pathol. Lab. Med. 1998; 122: 310-19.
6. Langlois NE, Lamb J, Eremin O, Heys SD. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: Relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products. J. Pathol. 1997; 182: 392-7.
7. Ikeda M, Shomori K, Endo K, Makino T, Matsuura T, Ito H. Frequent occurrence of apoptosis is an early event in the oncogenesis of human gastric carcinoma. Virchows Arch. 1998; 432: 43-7.
8. Mijic A, Ferencic Z, Belicza M et al. Apoptosis in human gastric polyps and adenocarcinomas: A stereological analysis. Hepatogastroenterology 1998; 45: 684-90.
9. Ikeguchi M, Cai J, Yamane N, Maeta M, Kaibara N. Clinical significance of spontaneous apoptosis in advanced gastric adenocarcinoma. Cancer 1999; 85: 2329-35.
10. Koshida Y, Saegusa M, Okayasu I. Apoptotosis, cell proliferation and expression of Bcl-2 and Bax in gastric carcinomas: Immunohistochemical and clinicopathological study. Br. J. Cancer 1997; 75: 367-73.
11. Shinohara T, Ohshima K, Murayama H et al. Apoptosis and proliferation in gastric carcinoma: The association with histological type. Histopathology 1996; 29: 123-9.
12. Lopez-Saez J, de la Torre C, Pincheira J, Gimenez-Martin G. Cell proliferation and cancer. Histol. Histopathol. 1998; 13: 1197-214.
13. Hockenbery D, Nuñez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-6.
14. Bissonnette RP, Echeverri F, Mahboubi A, Green DR. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992; 359: 552-4.
15. Sur M, Cooper K. bcl-2, p53 immunophenotypes and apoptosis in squamous cell carcinoma of the oesophagus. Histopathology 1998; 33: 87-8.
16. Lane DP. Cancer: p53, guardian of the genome. Nature 1992; 358: 15-16.
17. Hermeking H, Eick D. Mediation of c-Myc-induced apoptosis by p53. Science 1994; 265: 2091-3.
18. Gulley ML, Pulitzer DR, Eagan PA, Schneider BG. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. Hum. Pathol. 1996; 27: 20-7.
19. Ishii HH, Tamauchi H, Gobé GC. In the absence of Epstein-Barr virus infection, phorbol ester modulates apoptosis in cycloheximide-treated Burkitt's lymphoma (BJA-B) cells. Int. J. Exp. Pathol. 1997; 78: 123-31.
20. Cole MD, McMahon SB. The Myc oncoprotein: A critical evaluation of transactivation and target gene regulation. Oncogene 1999; 18: 2916-24.
21. Santoro E, Carlini M, Garofalo A, Carboni F, Santoro R, Castelli M. Gastric cancer. Clinico-biological updating and analysis of 400 operated cases. J. Exp. Clin. Cancer Res. 1998; 17: 175-85.
22. Kataoka M, Okabayashi T, Johira H et al. Aberration of p53 and DCC in gastric and colorectal cancer. Oncol. Rep. 2000; 7: 99-103.
23. Sanz-Ortega J, Steinberg SM, Moro Eet al. Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer. Histol. Histopathol. 2000; 15: 455-62.
24. Laurén P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. Acta Pathol. Microbiol. Scand. 1965; 64: 31-49.
25. Japanese Research Society for Gastric Cancer. Clinical, surgical, and conclusive findings. In: Nishi M, Omori Y, Miwa K, eds.Japanese Classification of Gastric Carcinoma, 1st English edn. Tokyo: Kanehara, 1995; 1-35.
26. Camilleri-Broët S, Martin A, Moreau A et al. Primary central nervous system lymphomas in 72 immunocompetent patients: Pathologic findings and clinical correlations. Am. J. Clin. Pathol. 1998; 110: 607-12.
27. Ng HK, Chen L. Apoptosis is associated with atypical or malignant change in meningiomas. An in situ labelling and immunohistchemical study. Histopathology 1998; 33: 64-70.
28. Ishii HH, Gobe G, Kawakubo Y, Sato Y, Ebihara Y. Interrelationship between Epstein-Barr virus infection in gastric carcinomas and the expression of apoptosis-associated proteins. Histopathology 2001; 38: 111-19.
29. Wu M-S, Shun C-T, Wu C-C et al. Epstein-Barr virus-associated gastric carcinomas: Relation to H. pylori infection and genetic alterations. Gastroenterology 2000; 118: 1031-8.
30. Landberg G, Roos G. Proliferating cell nuclear antigen and Ki-67 antigen expression in human haematopoietic cells during growth stimulation and differentiation. Cell Prolif. 1993; 26: 427-37.
31. Kerr J, Gobé GC, Winterford CM, Harmon BV. Anatomical methods in cell death. Methods Cell Biol. 1995; 46: 1-27.
32. Gobe G, Zhang XJ, Willgoss DA, Schoch E, Hogg NA, Endre ZH. Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J. Am. Soc. Nephrol. 2000; 11: 454-67.
33. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note. Hepatology 1995; 21: 1465-8.
34. Xiangming C, Natsugoe S, Takao Set al. Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer. Clin. Cancer Res. 2001; 7: 277-82.
35. Törmänen U, Nuorva K, Soini Y, Paakko P. Apoptotic activity is increased in parallel with the metaplasia-dysplasia-carcinoma sequence of the bronchial epithelium. Br. J. Cancer 1999; 79: 996-1002.
36. Harris CC. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies. J. Natl Cancer Inst. 1996; 88: 1442-55.
37. Soong R, Robbins PD, Dix BR et al. Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas. Hum. Pathol. 1996; 27: 1050-5.
38. Hong SI, Hong WS, Jang JJ et al. Alterations of p53 gene in primary gastric cancer tissues. Anticancer Res. 1994; 14: 1251-5.
39. Elenitoba-Johnson K, Medeiros L, Khorsand J, King TC. P53 expression in Reed-Sternberg cells dose not correlate with gene mutations in Hodgkin's disease. Am. J. Clin. Pathol. 1996; 106: 728-38.
40. Matsuno A, Nagashima T, Matsuura R et al. Correlation between MIB-1 staining index and the immunoreactivity of p53 protein in recurrent and non-recurrent meningiomas. Am. J. Clin. Pathol. 1996; 106: 776-81.
41. Evan GI, Wyllie AH, Gilbert C et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119-28.
42. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440-2.